Page 2 - Andreas Muehler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-News: Immunic AG: Immunic to Host MS R&D Day and Participate in Investor Conferences in April

EQS-News: Immunic AG: Immunic to Host MS R&D Day and Participate in Investor Conferences in April
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomSan franciscoUnited statesDaniel vittJessica breuPaula schwartzEdna kaplanDennis riedlAndreas muehlerHella kohlhofSclerosis ms researchDistribution servicesRx communications groupDevelopment rd dayHotel nikkoImmunic inc

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

NEW YORK, April 4, 2024 /PRNewswire/ Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and.

United kingdomSan franciscoUnited statesHella kohlhofAndreas muehlerEdna kaplanPaula schwartzJessica breuDaniel vittExchange commissionImmunic incSclerosis ms researchHotel nikkoDevelopment rd dayRx communications groupMultiple sclerosis

Vidofludimus calcium reduced NfL levels in progressive MS patients| Multiple Sclerosis News Today

Vidofludimus calcium reduced NfL levels in progressive MS patients| Multiple Sclerosis News Today
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Andreas muehlerJens kuhleDaniel vittUniversity hospital baselImmunic therapeutics

Vidofludimus calcium linked to neurofilament light chain reduction in MS

Vidofludimus calcium linked to neurofilament light chain reduction in MS
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Byrobert herpenShenaz baghaAndreas muehlerImmunic incRobert herpenImmunic therapeutics

ECTRIMS 2023: RRMS nerve damage reduced with vidofludimus calcium | Multiple Sclerosis News Today

ECTRIMS 2023: RRMS nerve damage reduced with vidofludimus calcium | Multiple Sclerosis News Today
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Daniel vittRobertj foxAndreas muehlerResearch in multiple sclerosisEuropean committee for treatmentAmericas committee for treatmentCleveland clinicEuropean committeeMultiple sclerosisAmericas committeeNeurofilament light chainVidofludimus calciumImmunic therapeuticsMultiple sclerosis news